Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
HiFiBiO Therapeutics
City of Hope Medical Center
Eastern Cooperative Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
City of Hope Medical Center
Rutgers, The State University of New Jersey
Dana-Farber Cancer Institute
UNICANCER
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
Indiana University
Duke University
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Duke University
University of Southampton
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center